FindMyKOL
Clinical trialNCT04178174RecruitingPhase 3Interventional

Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

SponsorCentre hospitalier de l'Université de Montréal (CHUM)Enrollment360Head and Neck CancerHuman Papilloma VirusOropharynx Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a randomized clinical trial comparing the outcomes of short-course chemoradiation consisting in stereotactic boost to the gross tumor and de-esclalated chemoradiation to the elective neck in human papilloma associated oropharynx cancer vs. the current standard 7-week course chemoradiation.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • David Palma, MD PhD

    London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    Principal Investigator
  • Houda Bahig, MD PhD

    Centre hospitalier de l'Université de Montréal (CHUM)

    Study Chair
  • Jack Phan, MD PhD

    M.D. Anderson Cancer Center

    Principal Investigator
  • Khalil Sultanem, MD

    Montreal Jewish General Hospital

    Principal Investigator
  • Phuc-Felix Nguyen-Tan, MD

    Centre hospitalier de l'Université de Montréal (CHUM)

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Bc Cancer - Kelowna

    Kelowna, British Columbia, Canada

    Recruiting
  • London Health Sciences Center

    London, Ontario, Canada

    Recruiting
  • Centre Hospitalier de L'Université de Montréal

    Montreal, Quebec, Canada

    Houda BahigPhuc-Félix Nguyen-Tan
    Recruiting
United States
  • University of Texas Md Anderson Cancer Center

    Houston, Texas, United States

    Jack Phan, MD PhD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Feb 2020
Primary completion
31 Dec 2028
Completion
31 Dec 2030
Last update posted
16 Nov 2026
Registered enrollment
360
Registry id
NCT04178174

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.